Mohammed El Adoui1, Stylianos Drisis2, Mohammed Benjelloun3. 1. Computer Science Unit, Faculty of Engineering, University of Mons, Mons, Belgium. Mohammed.Eladoui@umons.ac.be. 2. Jules Bordet Institute, Brussels, Belgium. 3. Computer Science Unit, Faculty of Engineering, University of Mons, Mons, Belgium.
Abstract
PURPOSE: This study aims to provide and optimize a performing algorithm for predicting the breast cancer response rate to the first round of chemotherapy using Magnetic Resonance Imaging (MRI). This provides an early recognition of breast tumor reaction to chemotherapy by using the Parametric Response Map (PRM) method. METHODS: PRM may predict the breast cancer response to chemotherapy by analyzing voxel-by-voxel temporal intra-tumor changes during one round of chemotherapy. Indeed, the tumor recognizes intra-tumor changes concerning its vascularity, which is an important criterion in the present study. This method is mainly based on spatial image affine registration between the breast tumor MRI volumes, acquired before and after the first cycle of chemotherapy, and region growing segmentation of the tumor volume. To evaluate our method, we used a retrospective study of 40 patients provided by a collaborating institute. RESULTS: PRM allows a color map to be created with the percentages of positive, negative and stable breast tumor response during the first round of chemotherapy, identifying each region with its response rate. We assessed the accuracy of the proposed method using technical and medical validation methods. The technical validation was based on landmarks-based registration and fully manual segmentation. The medical evaluation was based on the accuracy calculation of the standard reference of anatomic pathology. The p-values and the Area Under the Curve (AUC) of the Receiver Operating Characteristics were calculated to evaluate the proposed PRM method. CONCLUSION: We performed and evaluated the proposed PRM method to study and analyze the behavior of a tumor during the first round of chemotherapy, based on the intra-tumor changes of MR breast tumor images. The AUC obtained for the PRM method is considered as relevant in the early prediction of breast tumor response.
PURPOSE: This study aims to provide and optimize a performing algorithm for predicting the breast cancer response rate to the first round of chemotherapy using Magnetic Resonance Imaging (MRI). This provides an early recognition of breast tumor reaction to chemotherapy by using the Parametric Response Map (PRM) method. METHODS: PRM may predict the breast cancer response to chemotherapy by analyzing voxel-by-voxel temporal intra-tumor changes during one round of chemotherapy. Indeed, the tumor recognizes intra-tumor changes concerning its vascularity, which is an important criterion in the present study. This method is mainly based on spatial image affine registration between the breast tumor MRI volumes, acquired before and after the first cycle of chemotherapy, and region growing segmentation of the tumor volume. To evaluate our method, we used a retrospective study of 40 patients provided by a collaborating institute. RESULTS: PRM allows a color map to be created with the percentages of positive, negative and stable breast tumor response during the first round of chemotherapy, identifying each region with its response rate. We assessed the accuracy of the proposed method using technical and medical validation methods. The technical validation was based on landmarks-based registration and fully manual segmentation. The medical evaluation was based on the accuracy calculation of the standard reference of anatomic pathology. The p-values and the Area Under the Curve (AUC) of the Receiver Operating Characteristics were calculated to evaluate the proposed PRM method. CONCLUSION: We performed and evaluated the proposed PRM method to study and analyze the behavior of a tumor during the first round of chemotherapy, based on the intra-tumor changes of MR breast tumor images. The AUC obtained for the PRM method is considered as relevant in the early prediction of breast tumor response.
Authors: Wendie A Berg; Andriy I Bandos; Ellen B Mendelson; Daniel Lehrer; Roberta A Jong; Etta D Pisano Journal: J Natl Cancer Inst Date: 2015-12-28 Impact factor: 13.506
Authors: Manfred Kaufmann; Gunter von Minckwitz; Elefhterios P Mamounas; David Cameron; Lisa A Carey; Massimo Cristofanilli; Carsten Denkert; Wolfgang Eiermann; Michael Gnant; Jay R Harris; Thomas Karn; Cornelia Liedtke; Davide Mauri; Roman Rouzier; Eugen Ruckhaeberle; Vladimir Semiglazov; W Fraser Symmans; Andrew Tutt; Lajos Pusztai Journal: Ann Surg Oncol Date: 2011-12-23 Impact factor: 5.344
Authors: Robert M Lober; Yoon-Jae Cho; Yujie Tang; Patrick D Barnes; Michael S Edwards; Hannes Vogel; Paul G Fisher; Michelle Monje; Kristen W Yeom Journal: J Neurooncol Date: 2014-02-13 Impact factor: 4.130
Authors: Anwar R Padhani; Carmel Hayes; Laura Assersohn; Trevor Powles; Andreas Makris; John Suckling; Martin O Leach; Janet E Husband Journal: Radiology Date: 2006-03-16 Impact factor: 11.105
Authors: Roar Johansen; Line R Jensen; Jana Rydland; Pål E Goa; Kjell A Kvistad; Tone F Bathen; David E Axelson; Steinar Lundgren; Ingrid S Gribbestad Journal: J Magn Reson Imaging Date: 2009-06 Impact factor: 4.813
Authors: Luciano G Martelotto; Charlotte K Y Ng; Salvatore Piscuoglio; Britta Weigelt; Jorge S Reis-Filho Journal: Breast Cancer Res Date: 2014-05-20 Impact factor: 6.466